TY  - GEN
AU  - Tang,Shou-Hung
AU  - Huang,Hsu-Shan
AU  - Wu,Hong-Ui
AU  - Tsai,Yi-Ta
AU  - Chuang,Mei-Jen
AU  - Yu,Cheng-Ping
AU  - Huang,Shih-Ming
AU  - Sun,Guang-Huan
AU  - Chang,Sun-Yran
AU  - Hsiao,Pei-Wen
AU  - Yu,Dah-Shyong
AU  - Cha,Tai-Lung
TI  - Pharmacologic down-regulation of EZH2 suppresses bladder cancer in vitro and in vivo
SN  - 1949-2553
PY  - 2015///0730
KW  - Animals
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Apoptosis
KW  - drug effects
KW  - Carcinoma
KW  - drug therapy
KW  - Cell Growth Processes
KW  - Cell Line, Tumor
KW  - Down-Regulation
KW  - Drug Resistance
KW  - Emodin
KW  - Enhancer of Zeste Homolog 2 Protein
KW  - G2 Phase Cell Cycle Checkpoints
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - In Vitro Techniques
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Mice, Nude
KW  - Neoadjuvant Therapy
KW  - Neoplasm Staging
KW  - Polycomb Repressive Complex 2
KW  - antagonists & inhibitors
KW  - Proteasome Endopeptidase Complex
KW  - metabolism
KW  - Urinary Bladder Neoplasms
KW  - Xenograft Model Antitumor Assays
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.18632/oncotarget.1867
ER  -